Vertex Pharmaceuticals received a boost with Canada's approval of ALYFTREK for cystic fibrosis. This approval boosts sentiment. The stock saw a 7% rise over the past month amid broader market optimism ...

Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical ...

Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Corporation") announced today that its 2024 Schedule K-3 packages for Summit Midstream Partners, LP are now available online ...

HOUSTON, July 9, 2025 /PRNewswire/ -- Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Corporation") announced today that its 2024 Schedule K-3 packages for Summit Midstream ...

Medically reviewed by Allison Herries, RDNMedically reviewed by Allison Herries, RDN Vitamin K2 (menaquinones), a form of vitamin K, is found in some animal-based foods or fermented foods. It is ...

Item Second Irr. Trust FBO Anne Marie Westphal, a ten percent owner of Vertex (NASDAQ: VRTX), Inc. (NASDAQ: VERX), reported selling 23,767 shares of Class A Common Stock for approximately $836,410, ...

In other recent news, Vertex Inc . reported its first-quarter 2025 earnings, surpassing analyst expectations with an earnings per share (EPS) of $0.15, compared to the forecasted $0.13. The ...

Ono will assist with Vertex's clinical trials for povetacicept and handle marketing approvals in Japan and South Korea, focusing on IgAN and pMN with possible additional uses.

In the new age of college athletics NIL is king. Kansas State quarterback Avery Johnson showed off his NIL deals with both CVS and WTC Fiber.

The first tropical storm of the Eastern Pacific hurricane season could form as early as next week, according to forecasts.